Actively Recruiting
DNA Analysis of Blood and Tissue from Patients with Lung Cancer
Led by Massachusetts General Hospital · Updated on 2024-11-29
N/A
Participants Needed
2
Research Sites
1095 weeks
Total Duration
On this page
Sponsors
M
Massachusetts General Hospital
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
RATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help the study of cancer in the future. PURPOSE: This clinical trial is analyzing the DNA in blood and tissue samples from patients with lung cancer.
CONDITIONS
Official Title
DNA Analysis of Blood and Tissue from Patients with Lung Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Newly diagnosed primary lung cancer
- Patient is treated at Massachusetts General Hospital (MGH) or Boston Medical Center Cancer Center
You will not qualify if you...
- Vulnerable populations are excluded
- Patients with metastasis from another site to lung are excluded
- Patients with mesothelioma are excluded
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
Actively Recruiting
2
Harvard School of Public Health
Boston, Massachusetts, United States, 02115
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here